Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
553.50    -0.50 (-0.09%)
Bid:
553.50
Ask:
554.00
Spread: 0.50 (0.09%)
Market Cap: £2.45b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

10 Jul 2018 11:21

Tate & Lyle PLC

Notification of transaction by Persons Discharging Managerial Responsibilities

Tate & Lyle PLC (the ‘Company’) announces that a grant of options and awards over the Company’s ordinary shares of 25 pence each in the capital of the Company (‘Shares’) was made on 5 July 2018 under the Tate & Lyle Performance Share Plan 2012 (‘PSP’) and the Tate & Lyle Group Bonus Plan (‘GBP’) in respect of the year ended 31 March 2018 to Persons Discharging Managerial Responsibilities (‘PDMR’) as detailed in the table below:

PDMR

No. of Shares subject to PSP award

No. of Shares subject to GBP award

Nick Hampton (Chief Executive)

330,380

22,629
Rowan Adams 131,456 13,103
Joan Braca 200,936 2,041
Robert Gibber N/A 10,496
Melissa Law 163,847 8,290
Rob Luijten 146,137 14,567
Jim Stutelberg 174,163 28,241
Andrew Taylor 177,680 2,684

Awards under the PSP are structured as either nil-cost options or conditional awards. Options and awards granted under the PSP will only vest to the extent that certain performance criteria are satisfied by the Company over a three-year performance period which runs from 1 April 2018 to 31 March 2021. These criteria are described in the Annual Report 2018.

Further information on the operation of the GBP is provided in the Annual Report 2018.

No consideration is payable for the grant or exercise of the options or awards under the PSP or GBP.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Claire-Marie O’GradyCompany Secretary10 July 2018

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Nick Hampton
2. Reason for the notification
a) Position / status PDMR – Chief Executive
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of nil-cost options over shares for no consideration under the Tate & Lyle Performance Share Plan 2012 and Group Bonus Plan
c) Price(s) and volume(s)

Price(s)

Nil

Volume(s)

330,380

Price(s)

Nil

Volume(s)

22,629

d) Aggregated information

Aggregated volume Price

353,009Nil

e) Date of the transaction 2018-07-05
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Rowan Adams
2. Reason for the notification
a) Position / status PDMR – Executive VP, Corporate Affairs
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of nil-cost options over shares for no consideration under the Tate & Lyle Performance Share Plan 2012 and Group Bonus Plan
c) Price(s) and volume(s)

Price(s)

Nil

Volume(s)131,456

Price(s)Nil

Volume(s)13,103

d) Aggregated information

Aggregated volume Price

144,559Nil

e) Date of the transaction 2018-07-05
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Joan Braca
2. Reason for the notification
a) Position / status PDMR - President, Food & Beverage Solutions
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of a conditional award over shares for no consideration under the Tate & Lyle Performance Share Plan 2012 and Group Bonus Plan
c) Price(s) and volume(s)

Price(s)

Nil

Volume(s)200,936

Price(s)Nil

Volume(s)2,041

d) Aggregated information

Aggregated volume Price

202,977Nil

e) Date of the transaction 2018-07-05
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Robert Gibber
2. Reason for the notification
a) Position / status PDMR – Executive VP, General Counsel
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of nil-cost options over shares for no consideration under the Tate & Lyle Group Bonus Plan
c) Price(s) and volume(s)

Price(s)Nil

Volume(s)10,496

d) Aggregated information

Aggregated volume Price

10,496Nil

e) Date of the transaction 2018-07-05
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Melissa Law
2. Reason for the notification
a) Position / status PDMR – President, Global Operations
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of a conditional award over shares for no consideration under the Tate & Lyle Performance Share Plan 2012 and Group Bonus Plan
c) Price(s) and volume(s)

Price(s)Nil

Volume(s)163,847

Price(s)Nil

Volume(s)8,290

d) Aggregated information

Aggregated volume Price

172,137Nil

e) Date of the transaction 2018-07-05
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Rob Luijten
2. Reason for the notification
a) Position / status PDMR – Executive VP, Human Resources
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of nil-cost options over shares for no consideration under the Tate & Lyle Performance Share Plan 2012 and Group Bonus Plan
c) Price(s) and volume(s)

Price(s)

Nil

Volume(s)146,137

Price(s)Nil

Volume(s)14,567

d) Aggregated information

Aggregated volume Price

160,704Nil

e) Date of the transaction 2018-07-05
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Jim Stutelberg
2. Reason for the notification
a) Position / status PDMR - President, Primary Products
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of a conditional award over shares for no consideration under the Tate & Lyle Performance Share Plan 2012 and Group Bonus Plan
c)

Price(s) and volume(s)

Price(s)

Nil

Volume(s)174,163

Price(s)Nil

Volume(s)28,241

d) Aggregated information

Aggregated volume Price

202,404Nil

e) Date of the transaction 2018-07-05
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of PDMR / person closely associated with them (“PCA”)
a) Name Andrew Taylor
2. Reason for the notification
a) Position / status PDMR - President, Innovation and Commercial Development
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of a conditional award over shares for no consideration under the Tate & Lyle Performance Share Plan 2012 and Group Bonus Plan
c) Price(s) and volume(s)

Price(s)

Nil

Volume(s)177,680

Price(s)Nil

Volume(s)2,684

d) Aggregated information

Aggregated volume Price

180,364Nil

e) Date of the transaction 2018-07-05
f) Place of the transaction Outside a trading venue

View source version on businesswire.com: https://www.businesswire.com/news/home/20180710005458/en/

Copyright Business Wire 2018

Date   Source Headline
2nd Mar 20262:00 pmRNSHolding(s) in Company
26th Feb 20267:00 amRNSTrading Statement
23rd Feb 202610:00 amRNSHolding(s) in Company
17th Feb 202612:00 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSDirectorate change
15th Jan 20269:00 amRNSHolding(s) in Company
12th Jan 202610:00 amRNSHolding(s) in Company
7th Jan 20264:30 pmRNSDirector/PDMR Shareholding
7th Jan 20262:30 pmRNSBlock listing Interim Review
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
11th Dec 202512:18 pmRNSDirector/PDMR Shareholding
9th Dec 20259:00 amRNSHolding(s) in Company
27th Nov 202510:00 amRNSDirector/PDMR Shareholding
11th Nov 20254:30 pmRNSDirector/PDMR Shareholding
10th Nov 20252:40 pmRNSDirector Declaration
6th Nov 20257:00 amRNSHalf-year Financial Report
5th Nov 20252:15 pmRNSHolding(s) in Company
3rd Nov 20255:00 pmRNSHolding(s) in Company
29th Oct 20252:00 pmRNSHolding(s) in Company
23rd Oct 20254:15 pmRNSHolding(s) in Company
21st Oct 20253:30 pmRNSHolding(s) in Company
16th Oct 202512:00 pmRNSHolding(s) in Company
8th Oct 202512:00 pmRNSHolding(s) in Company
6th Oct 20254:30 pmRNSDirector/PDMR Shareholding
6th Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 202510:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSPre-close statement
2nd Sep 20258:00 amRNSTotal Voting Rights
11th Aug 20251:00 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSDirector/PDMR Shareholding
1st Aug 202511:00 amRNSTotal Voting Rights
24th Jul 20252:30 pmRNSResult of Annual General Meeting 2025
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
1st Jul 20253:30 pmRNSBlock listing Interim Review
1st Jul 20257:00 amRNSTate & Lyle Capital Markets Event
13th Jun 20253:00 pmRNSHolding(s) in Company
11th Jun 20254:30 pmRNSDirector/PDMR Shareholding
5th Jun 20252:30 pmRNSAnnual Financial Report and Notice of Meeting 2025
5th Jun 20252:00 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:30 pmRNSTotal Voting Rights
28th May 202512:00 pmRNSDirector/PDMR Shareholding
27th May 202512:00 pmRNSDirector/PDMR Shareholding
23rd May 202510:00 amRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSFinal Results
14th May 20259:00 amRNSHolding(s) in Company
1st May 20253:00 pmRNSHolding(s) in Company
29th Apr 20253:30 pmRNSHolding(s) in Company
28th Apr 20255:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.